Zobrazeno 1 - 7 of 7 pro vyhledávání: '"Pei-Jhang Chiang"'
1
Akademický článek
Risk and predictors of patients receiving neoadjuvant chemotherapy followed by radical cystectomy or transurethral resection alone for muscle-invasive bladder cancer: A single-institute experience
Autor: Pei-Jhang Chiang, Kai-Hsiung Ko, En Meng, Tai-Lung Cha, Guang-Haun Sun, Dah-Shyong Yu, Chien-Chang Kao
Publikováno v: Journal of Medical Sciences, Vol 42, Iss 4, Pp 175-179 (2022)
Background: Upper urinary tract urothelial carcinoma and muscle-invasive bladder cancer (MIBC) incidence rates are high in Taiwan. Our patients with MIBC are commonly managed with a radical cystectomy (RC); however, recurrence rates remain high. Aim:
Externí odkaz: https://doaj.org/article/e43a0ed1636d4a648345b2fe6e6e8e18
Zobrazit plný text záznamu
2
Akademický článek
Primary melanoma of the vagina with urethral invasion: A case report and literature review
Autor: Meng-Hung Shih, Pei-Jhang Chiang, En Meng, Dah-Shyong Yu
Publikováno v: Taiwanese Journal of Obstetrics & Gynecology, Vol 60, Iss 5, Pp 969-970 (2021)
Externí odkaz: https://doaj.org/article/78313faaf6634eaea551350204af9df8
Zobrazit plný text záznamu
3
Akademický článek
Programmed Cell Death Ligand 1 Expression in Circulating Tumor Cells as a Predictor of Treatment Response in Patients with Urothelial Carcinoma
Autor: Pei-Jhang Chiang, Ting Xu, Tai-Lung Cha, Yi-Ta Tsai, Shu-Yu Liu, Sheng-Tang Wu, En Meng, Chih-Wei Tsao, Chien-Chang Kao, Chin-Li Chen, Guang-Huan Sun, Dah-Shyong Yu, Sun-Yran Chang, Ming-Hsin Yang
Publikováno v: Biology, Vol 10, Iss 7, p 674 (2021)
Programmed cell death ligand 1 (PD-L1) inhibitors are commonly used in treating advanced-stage urothelial carcinoma (UC). Therefore, this study evaluated the relationship between PD-L1 expression in circulating tumor cells (CTCs) and treatment respon
Externí odkaz: https://doaj.org/article/8bac7e5115d443b087b8ee97f992bbe8
Zobrazit plný text záznamu
5
Programmed Cell Death Ligand 1 Expression in Circulating Tumor Cells as a Predictor of Treatment Response in Patients with Urothelial Carcinoma
Autor: Chin-Li Chen, Dah-Shyong Yu, Shu-Yu Liu, Tai-Lung Cha, Ming-Hsin Yang, En Meng, Pei-Jhang Chiang, Guang-Huan Sun, Yi-Ta Tsai, Sun-Yran Chang, Chien-Chang Kao, Sheng-Tang Wu, Ting Xu, Chih-Wei Tsao
Publikováno v: Biology, Vol 10, Iss 674, p 674 (2021)
Biology
Volume 10
Issue 7
Simple Summary Programmed cell death ligand 1 (PD-L1) inhibitors are commonly used in treating advanced-stage urothelial carcinoma. Contrary to evaluating PD-L1 expression in tumor biopsy samples, this study assessed whether PD-L1 expression in circu
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2b8b3ca9744413b43f81164be80bc7d
https://doi.org/10.3390/biology10070674
Zobrazit plný text záznamu
6
Kidney Transplantation from an extracorporeal membrane oxygenation-supported brain-dead donor
Autor: Yu-Chun Lin, Chiao-Ching Li, Sheng-Tang Wu, Pei-Jhang Chiang, Meng-Han Chou, Shou-Hung Tang
Publikováno v: Medicine
Rationale: Extracorporeal membrane oxygenation (ECMO) can deliver effective respiratory and circulatory maintenance to organ donors, improve organ function, and shorten warm ischemic time before harvesting. However, ECMO-supported brain-dead donors (
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::381ed6ddf4f5d6e0f5e06188723c6360
https://doi.org/10.1097/md.0000000000011106
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje